GMED - Globus Medical, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures4

Market Cap (intraday) 5.86B
Enterprise Value 5.36B
Trailing P/E 29.82
Forward P/E 25.45
PEG Ratio (5 yr expected) 2.26
Price/Sales (ttm)5.59
Price/Book (mrq)3.06
Enterprise Value/Revenue 5.01
Enterprise Value/EBITDA 17.03

Trading Information

Stock Price History

Beta (5Y Monthly) 1.06
52-Week Change 3-20.53%
S&P500 52-Week Change 31.77%
52 Week High 380.04
52 Week Low 350.92
50-Day Moving Average 356.24
200-Day Moving Average 363.50

Share Statistics

Avg Vol (3 month) 31.43M
Avg Vol (10 day) 31.3M
Shares Outstanding 579.9M
Implied Shares Outstanding 6N/A
Float 877.02M
% Held by Insiders 11.08%
% Held by Institutions 199.82%
Shares Short (May 14, 2023) 47.7M
Short Ratio (May 14, 2023) 45
Short % of Float (May 14, 2023) 49.74%
Short % of Shares Outstanding (May 14, 2023) 47.67%
Shares Short (prior month Apr 13, 2023) 45.78M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 30, 2023


Profit Margin 18.82%
Operating Margin (ttm)22.95%

Management Effectiveness

Return on Assets (ttm)7.39%
Return on Equity (ttm)10.88%

Income Statement

Revenue (ttm)1.07B
Revenue Per Share (ttm)10.68
Quarterly Revenue Growth (yoy)20.00%
Gross Profit (ttm)759.12M
EBITDA 314.83M
Net Income Avi to Common (ttm)201.21M
Diluted EPS (ttm)1.95
Quarterly Earnings Growth (yoy)29.00%

Balance Sheet

Total Cash (mrq)504.37M
Total Cash Per Share (mrq)5.03
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)6.39
Book Value Per Share (mrq)19.08

Cash Flow Statement

Operating Cash Flow (ttm)187.09M
Levered Free Cash Flow (ttm)89.68M